The Drug Enforcement Administration received 38,000 comments on its proposed rule that would roll back COVID-19 flexibilities for the prescribing of controlled substances via telemedicine. In response, the DEA chose to temporarily extend the flexibilities.
The post Telehealth Companies Applaud DEA For Delaying Telemedicine Restrictions Of Controlled Substances appeared first on Above the Law.
The Drug Enforcement Administration received 38,000 comments on its proposed rule that would roll back COVID-19 flexibilities for the prescribing of controlled substances via telemedicine.…
Talkiatry, Array Behavioral Care, Iris Telehealth, and Quartet Health sent a letter to the DEA asking for a special registration process that would allow for…
The DEA proposed a rule back in March that would roll back some of the COVID-19 flexibilities for the virtual prescribing of controlled substances, but…
[I’m far behind in my blogging queue, especially with respect to the social media addiction rulings.] I previously summarized this case: Rogalinski made several posts…
By guest blogger Lisa Ramsey, Professor of Law, University of San Diego School of Law The Supreme Court will likely hold in Elster that Section…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Responses